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Abstract
Listeria monocytogenes is an opportunistic Gram-positive bacterial pathogen responsible for
listeriosis, a human foodborne disease. Its cell wall is densely decorated with wall teichoic
acids (WTAs), a class of anionic glycopolymers that play key roles in bacterial physiology,
including protection against the activity of antimicrobial peptides (AMPs). In other Gram-
positive pathogens, WTAmodification by amine-containing groups such as D-alanine was
largely correlated with resistance to AMPs. However, in L.monocytogenes, whereWTA
modification is achieved solely via glycosylation, WTA-associated mechanisms of AMP re-
sistance were unknown. Here, we show that the L-rhamnosylation of L.monocytogenes
WTAs relies not only on the rmlACBD locus, which encodes the biosynthetic pathway for L-
rhamnose, but also on rmlT encoding a putative rhamnosyltransferase. We demonstrate that
this WTA tailoring mechanism promotes resistance to AMPs, unveiling a novel link between
WTA glycosylation and bacterial resistance to host defense peptides. Using in vitro binding
assays, fluorescence-based techniques and electron microscopy, we show that the pres-
ence of L-rhamnosylated WTAs at the surface of L.monocytogenes delays the crossing of
the cell wall by AMPs and postpones their contact with the listerial membrane. We propose
that WTA L-rhamnosylation promotes L.monocytogenes survival by decreasing the cell wall
permeability to AMPs, thus hindering their access and detrimental interaction with the plas-
ma membrane. Strikingly, we reveal a key contribution of WTA L-rhamnosylation for L.
monocytogenes virulence in a mouse model of infection.
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Author Summary
Listeria monocytogenes is a foodborne bacterial pathogen that preferentially infects immu-
nocompromised hosts, eliciting a severe and often lethal disease. In humans, clinical mani-
festations range from asymptomatic intestinal carriage and gastroenteritis to harsher
systemic states of the disease such as sepsis, meningitis or encephalitis, and fetal infections.
The surface of L.monocytogenes is decorated with wall teichoic acids (WTAs), a class of
carbohydrate-based polymers that contributes to cell surface-related events with implica-
tions in physiological processes, such as bacterial division or resistance to antimicrobial
peptides (AMPs). The addition of other molecules to the backbone of WTAs modulates
their chemical properties and consequently their functionality. In this context, we studied
the role of WTA tailoring mechanisms in L.monocytogenes, whose WTAs are strictly dec-
orated with monosaccharides. For the first time, we link WTA glycosylation with AMP re-
sistance by showing that the decoration of L.monocytogenesWTAs with L-rhamnose
confers resistance to host defense peptides. We suggest that this resistance is based on
changes in the permeability of the cell wall that delay its crossing by AMPs and therefore
promote the protection of the bacterial membrane integrity. Importantly, we also demon-
strate the significance of this WTA modification in L.monocytogenes virulence.
Introduction
Listeria monocytogenes (Lm) is a ubiquitous Gram-positive bacterium and the causative agent
of listeriosis, a human foodborne disease with high incidence and morbidity in immunocom-
promised hosts and other risk groups, such as pregnant women, neonates and the elderly.
Clinical manifestations range from febrile gastroenteritis to septicemia, meningitis and enceph-
alitis, as well as fetal infections that can result in abortion or postnatal health complications [1].
The most invasive and severe forms of the disease are a consequence of the ability of this patho-
gen to overcome important physiological barriers (intestinal epithelium, blood-brain barrier
and placenta) by triggering its internalization and promoting its intracellular survival into
phagocytic and non-phagocytic cells. Once inside a host cell, a tightly coordinated life cycle,
whose progression is mediated by several specialized bacterial factors, enables Lm to proliferate
and spread to neighboring cells and tissues [2, 3].
The Lm cell wall is composed of a thick peptidoglycan multilayer that serves as a scaffold for
the anchoring of proteins, among which are several virulence factors [4], and of glycopolymers
such as teichoic acids, which account for up to 70% of the protein-free cell wall mass [5, 6].
These anionic polymers are divided into membrane-anchored teichoic acids (lipoteichoic
acids, LTAs) and peptidoglycan-attached teichoic acids (wall teichoic acids, WTAs). In Listeria,
WTAs are mainly composed of repeated ribitol-phosphate subunits, whose hydroxyl groups
can be substituted with a diversity of monosaccharides [5]. While the polymer structure and
the chemical identity of the substituent groups of LTAs are rather conserved across listeriae [7,
8], they display a high variability in WTAs, even within the same species [9]. Specific WTA
substitution patterns are characteristic of particular Lm serotypes: N-acetylglucosamine is com-
mon to serogroups 1/2 and 3, and to serotype 4b, but serogroup 1/2 also contains L-rhamnose,
whereas serotype 4b displays D-glucose and D-galactose [10]. The broad structural and chemi-
cal similarity of LTAs andWTAs results in a considerable degree of functional redundancy,
which has complicated the characterization of these macromolecules and the assignment of
specific biological roles. However, studies on Gram-positive bacteria have revealed their contri-
bution to important physiological functions (e.g. cell envelope cationic homeostasis [11],
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regulation of autolysin activity [12], assembly of cell elongation and division machineries [13],
defense against antimicrobial peptides [14]) and to virulence-promoting processes, such as ad-
hesion and colonization of host tissues [15, 16].
Antimicrobial peptides (AMPs) are a large family of small peptides (<10 kDa) produced by
all forms of living organisms [17], which constitute a major player of the innate immune re-
sponse against microbial pathogens. Despite their structural diversity, the majority of AMPs
share both cationic and amphipathic properties that favor respectively their interaction with
the negatively charged prokaryotic surface and insertion into the plasma membrane [17, 18].
Subsequent pore formation or other AMP-mediated membrane-disrupting mechanisms in-
duce bacterial death through direct cell lysis or deleterious interaction with intracellular targets
[19]. Bacteria have evolved multiple strategies to avert killing by AMPs [20, 21]. One strategy
consists in the modification of their cell surface charge, a process achieved mainly by masking
anionic glycopolymers with positively charged groups, thus decreasing their affinity to AMPs.
In Gram-positive pathogens, D-alanylation of teichoic acids is a well-characterized mechanism
and was demonstrated to be important for bacterial resistance to host-secreted AMPs [22, 23].
In contrast, the contribution of WTA glycosylation mechanisms in AMP resistance has not yet
been investigated.
We have previously reported genome-wide transcriptional changes occurring in Lm strain
EGD-e during mouse infection [24]. Our analysis revealed an elevated in vivo expression of
the lmo1081-1084 genes, here renamed as rmlACBD because of the high homology of the cor-
responding proteins with enzymes of the L-rhamnose biosynthesis pathway. In this work, we
show that the decoration of LmWTAs with L-rhamnose requires the expression of not only
the rmlACBD locus but also of rmlT, an upstream-flanking gene encoding a putative rhamno-
syltransferase. We also demonstrate that Lm becomes more susceptible to AMPs in the ab-
sence of WTA L-rhamnosylation and predict that this effect is due to an increase of the Lm
cell wall permeability to these bactericides, which results in a faster disruption of the plasma
membrane integrity with lethal consequences for the bacterial cell. Importantly, we present
evidence that this WTA tailoring process is required for full-scale Lm virulence in the mouse
model of infection.
Results
The rmlACBD locus is required for the presence of L-rhamnose in Lm
WTAs
To identify new Lm genes potentially critical for the infectious process, we previously per-
formed the first in vivo transcriptional profiling of Lm EGD-e. Among the Lm genes displaying
the largest increase in transcription throughout infection, we identified a set of previously
uncharacterized genes that are included in a pentacistronic operon (lmo1080 to lmo1084) [25].
This operon is found in L.monocytogenes strains belonging to serogroups 1/2, 3 and 7, and is
absent from serogroup 4 strains [26] (Fig 1). Interestingly, aside from Listeria seeligeri 1/2b
strains, this locus is not found in any other Listeria spp., such as the nonpathogenic Listeria
innocua or the ruminant pathogen Listeria ivanovii, which pinpoints it as a genetic feature of a
particular subset of pathogenic Listeria strains and suggests that its expression may be impor-
tant to Listeria pathogenesis in humans.
The four proteins encoded by the lmo1081-lmo1084 genes share a high amino acid sequence
homology with the products of the rmlABCD gene cluster. These genes are widely distributed
among Gram-negative (e.g. Salmonella enterica [27], Shigella flexneri [28], Vibrio cholerae [29],
Pseudomonas aeruginosa [30]) and Gram-positive species (e.g.Mycobacterium tuberculosis
[31], Streptococcus mutans [32], Geobacillus tepidamans [33], Lactobacillus rhamnosus [34])
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Fig 1. Genes encoding the l-rhamnose biosynthesis pathway are distributed in listeriae and other bacterial species.Comparison of the genomic
organization of the L-rhamnose pathway genes in the genus Listeria and other bacteria. The corresponding species and strains are indicated on the left (Lmo,
Listeria monocytogenes; Lin, Listeria innocua; Lse, Listeria seeligeri; Liv, Listeria ivanovii; Lwe, Listeria welshimeri; Smu, Streptococcus mutans;Mtu,
Mycobacterium tuberculosis; Sen, Salmonella enterica serovar Typhimurium; Sfl, Shigella flexneri; Pae, Pseudomonas aeruginosa) and listerial serotypes
are indicated on the right. Genes are represented by boxed arrows and their names are provided for strain EGD-e. Operons are underlined by dashed arrows
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(Fig 1), the majority of which being known pathogens or potentially pathogenic. Despite the
inter-species variability observed in the genetic organization of the rml genes, the respective
proteins exhibit a remarkable degree of conservation (S1 Table in S1 Text). In light of this, we
renamed the lmo1081-lmo1084 genes to rmlACBD, respectively (Fig 1).
The RmlABCD proteins catalyze the conversion of glucose-1-phosphate to a thymidine-di-
phosphate (dTDP)-linked form of L-rhamnose [35] (S1A Fig in S1 Text), which is a component
of the WTAs from most Listeria strains possessing the rml genes [6]. To address the role of
rmlACBD in LmWTA glycosylation with L-rhamnose, we constructed an Lm EGD-e derivative
mutant strain lacking the rmlACBD locus (ΔrmlACBD) (S2A Fig in S1 Text) and investigated if
the absence of these genes could affect the WTA L-rhamnosylation status. We prepared WTA
hydrolysates from exponential phase cultures of wild type (EGD-e), ΔrmlACBD and a comple-
mented ΔrmlACBD strain expressing rmlACBD from its native promoter within an integrative
plasmid (ΔrmlACBD+rmlACBD). Samples were resolved by native PAGE and the gel stained
with Alcian blue to visualize WTA polymer species. A mutant strain unable to synthesize
WTAs (ΔtagO1ΔtagO2) [36] was used to confirm that the detected signal corresponds to
WTAs. Compared to the wild type sample, the ΔrmlACBDWTAs displayed a shift in migra-
tion, which was reverted to a wild type-like profile in WTAs from the ΔrmlACBD+rmlACBD
sample (Fig 2A), indicating that the native WTA composition requires the presence of the
rmlACBD genes. To confirm this, we investigated the WTA carbohydrate composition from
these strains. WTA polymers were isolated from cell walls purified from bacteria in exponential
growth phase, hydrolyzed and analyzed by high-performance anion exchange chromatography
coupled with pulsed amperometric detection (HPAEC-PAD) to detect monosaccharide spe-
cies. WTA extracts obtained from ΔrmlACBD bacteria completely lacked L-rhamnose, in con-
trast to those isolated from the parental wild type strain (Fig 2B). The role of rmlACBD in Lm
WTA L-rhamnosylation was definitely confirmed by the analysis of WTAs from ΔrmlACBD
+rmlACBD bacteria, in which L-rhamnose was detected at levels similar to those observed in
the wild type sample (Fig 2B). Similar observations were made with purified cell wall samples
that contain WTAs still attached to the peptidoglycan matrix (S3A Fig in S1 Text). The absence
of muramic acid, one of the peptidoglycan building blocks, fromWTA extracts (Fig 2B) indi-
cates that L-rhamnose is specifically associated with WTAs and is not a putative peptidoglycan
contaminant. This is corroborated by the absence of L-rhamnose in purified peptidoglycan
samples (Fig 2C).
WTAs have been identified as important regulators of peptidoglycan cross-linking and
maturation [37]. To investigate if L-rhamnose decoration of WTAs has any involvement in
the maturation of the Lm peptidoglycan, we performed HPLC analysis of the muropeptide
composition of mutanolysin-digested peptidoglycan samples from wild type, ΔrmlACBD and
ΔrmlACBD+rmlACBD bacteria. No differences in the nature and relative amount of muropep-
tide species were observed between strains (S3B Fig in S1 Text), ruling out a role for WTA
L-rhamnosylation in the consolidation of the peptidoglycan architecture. Overall, these results
confirm that a functional rmlACBD locus is required for the association of L-rhamnose with
LmWTAs, likely by providing the molecular machinery responsible for the synthesis of
L-rhamnose.
and homologs of the rml genes are shown with identical colors. Numbered gaps indicate the genetic distance (Mb, mega base pairs) between rml genes
located far apart in the chromosome. Bacterial genomic sequences were obtained from NCBI database and chromosomal alignments assembled using
Microbial Genomic context Viewer and Adobe Illustrator.
doi:10.1371/journal.ppat.1004919.g001
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RmlT is required for the incorporation of L-rhamnose into LmWTAs
The rml operon in Lm includes a fifth gene, lmo1080, located upstream of rmlA (Fig 1), which
codes for a protein similar to the B. subtilisminor teichoic acid biosynthesis protein GgaB,
shown to possess sugar transferase activity [38]. Conserved domain analysis of the translated
Lmo1080 amino acid sequence revealed that its N-terminal region is highly similar (e-value
Fig 2. A functional rml operon is required for glycosylation of LmWTAs with l-rhamnose. (A) Alcian blue-stained 20% polyacrylamide gel containing
WTA extracts from logarithmic-phase cultures of different Lm strains. (B–D) HPAEC-PAD analyses of the sugar composition of the (B) WTA, (C)
peptidoglycan and (D) cytoplasmic fractions isolated from the indicated Lm strains. Samples were hydrolyzed in 3 M HCl (2 h, 95°C), diluted with water and
lyophilized before injection into the HPLC equipment. Standards for ribitol (Rib), L-rhamnose (Rha), glucosamine (GlcN), and muramic acid (Mur) were eluted
under identical conditions to allow peak identification.
doi:10.1371/journal.ppat.1004919.g002
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10–22) to a GT-A family glycosyltransferase domain (S1B Fig in S1 Text). In GT-A enzymes,
this domain forms a pocket that accommodates the nucleotide donor substrate for the glycosyl
transfer reaction, and contains a signature DxD motif necessary to coordinate a catalytic diva-
lent cation [39]. This motif is also found within the predicted glycosyltransferase domain
sequence of Lmo1080 as a DHD tripeptide (S1B Fig in S1 Text). For these reasons, we investi-
gated whether Lmo1080, which we renamed here RmlT (for L-rhamnose transferase), was in-
volved in the L-rhamnosylation of LmWTAs. We constructed an Lm EGD-e mutant strain
lacking rmlT (S2A Fig in S1 Text) and analyzed the structure and sugar composition of its
WTAs as described above. WTAs isolated from ΔrmlT bacteria displayed a faster migration in
gel (Fig 2A) and did not contain any trace of L-rhamnose (Fig 2B), fully recapitulating the
ΔrmlACBD phenotype. Reintroduction of a wild type copy of rmlT into the mutant strain
(ΔrmlT+rmlT) resulted in a phenotype that resembles that of the wild type strain, with regards
to WTA gel migration profile (Fig 2A) and presence of L-rhamnose in the WTA fraction
(Fig 2B).
To discard the possibility that the deletion of rmlT exerted a negative polar effect on the
downstream expression of rmlACBD, potentially disrupting the synthesis of L-rhamnose used
for WTA glycosylation, we compared the transcription of the rmlACBD genes in the wild type
and ΔrmlT Lm strains by quantitative real-time PCR. Transcript levels were unchanged in the
ΔrmlT background as compared to the wild type strain (S2B Fig in S1 Text), indicating that the
deletion of rmlT did not interfere with the transcription of rmlACBD. To definitely confirm
that Lm ΔrmlT still holds the capacity to synthesize L-rhamnose, being only incapable to incor-
porate it in nascent WTA polymers, we evaluated the presence of L-rhamnose in the cyto-
plasmic compartment of this strain. The intracellular content of early exponential-phase
bacteria from the wild type, ΔrmlACBD and ΔrmlT strains was extracted, hydrolyzed and ana-
lyzed by HPAEC-PAD to compare the sugar composition of cytoplasmic extracts. As shown in
Fig 2D, a peak corresponding to L-rhamnose was detected in the cytoplasmic samples from the
wild type and ΔrmlT strains, but not from the ΔrmlACBD strain, clearly demonstrating that, as
opposed to ΔrmlACBD bacteria, ΔrmlT bacteria retain a functional L-rhamnose biosynthesis
pathway. These results indicate that the depletion of L-rhamnose observed in ΔrmlTWTAs is a
consequence of the absence of the WTA L-rhamnosyltransferase activity performed by RmlT.
Therefore, we propose RmlT as the glycosyltransferase in charge of decorating LmWTAs with
L-rhamnose.
WTA L-rhamnosylation promotes Lm resistance to AMPs
WTAs were previously associated with bacterial resistance against salt stress [40] and host de-
fense effectors, such as lysozyme [37, 41]. We thus investigated the potential involvement of
WTA L-rhamnosylation in these processes by assessing the growth of the ΔrmlACBD and
ΔrmlT strains in the presence of high concentrations of either NaCl or lysozyme. As shown in
Fig 3A, no significant difference was observed between the growth of the wild type and the two
mutant strains in BHI broth containing 5% NaCl. Similarly, no difference was detected be-
tween the growth behavior of these strains after the addition of different concentrations of lyso-
zyme (50 μg/ml and 1 mg/ml) to bacterial cultures in the exponential phase (Fig 3B). As
expected, we observed an immediate and significant decrease in the survival of the lysozyme-
hypersensitive ΔpgdAmutant [42] (Fig 3B). These data demonstrate that Lm does not require
L-rhamnosylated WTAs to grow under conditions of high osmolarity nor to resist the cell wall-
degrading activity of lysozyme.
WTAs were also found to be involved in bacterial resistance to host-secreted defense pep-
tides [14, 43]. To investigate the role of WTA L-rhamnosylation in Lm resistance to AMPs, we
Listeria monocytogenesWTA L-Rhamnosylation and AMP Resistance
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evaluated the in vitro survival of wild type, ΔrmlACBD and ΔrmlT Lm, as well as of the respec-
tive complemented strains, in the presence of biologically active synthetic forms of AMPs pro-
duced by distinct organisms: gallidermin, a bacteriocin from the Gram-positive bacterium
Staphylococcus gallinarum [44]; CRAMP, a mouse cathelicidin [45], or its human homolog LL-
37 [46]. After two hours of co-incubation with different AMP concentrations, surviving bacte-
ria were enumerated by plating in solid media. The overall survival levels of Lm varied with
each AMP, evidencing their distinct antimicrobial effectiveness (S4 Fig in S1 Text). However,
when compared to the wild type strain, the ΔrmlACBD and ΔrmlTmutants displayed a consis-
tent decrease in their survival levels in the presence of any of the three AMPs (Fig 3C), in a
dose-dependent manner (S4 Fig in S1 Text). Restoring WTA L-rhamnosylation through genet-
ic complementation of the mutant strains resulted in an increase of the survival rate to wild
type levels. This result demonstrated the important contribution of L-rhamnosylated WTAs to-
wards Lm resistance against AMPs, pointing to a role for WTA glycosylation in bacterial im-
mune evasion mechanisms.
Fig 3. WTA l-rhamnosylation promotes Lm resistance against AMPs. (A) Growth of Lm strains in BHI broth supplemented with 5% NaCl. A growth curve
of wild type EGD-e in the absence of 5% NaCl was included as a control for optimal growth. (B) Growth of mid-exponential-phase Lm strains untreated (black
symbols) or challenged with 50 μg/ml (gray symbols) or 1 mg/ml (white symbols) of lysozyme. Optical density of the shaking cultures was monitored
spectrophotometrically at 600 nm. (C) Quantification of viable bacteria after treatment of mid-exponential-phase Lm strains (2 h, 37°C) with gallidermin (1 μg/
ml), CRAMP or LL-37 (5 μg/ml). Averaged replicate values from AMP-treated samples were normalized to untreated control samples and the transformed
data expressed as the percentage of surviving bacteria relative to wild type Lm (set at 100). Data represent mean±SD of three independent experiments.
*, p0.05; ***, p0.001.
doi:10.1371/journal.ppat.1004919.g003
Listeria monocytogenesWTA L-Rhamnosylation and AMP Resistance
PLOS Pathogens | DOI:10.1371/journal.ppat.1004919 May 22, 2015 8 / 29
WTA L-rhamnosylation interferes with Lm cell wall crossing by AMPs
The increased AMP susceptibility of Lm strains defective in WTA L-rhamnosylation suggests
that this process is required to hinder the bactericidal activity of AMPs. Since AMPs generally
induce bacterial death by disrupting the integrity of the plasma membrane, we hypothesized
that the higher susceptibility of the ΔrmlACBD and ΔrmlTmutant strains resulted from an in-
creased AMP-mediated destabilization of the Lmmembrane. In this context, two scenarios
were envisioned: i) AMPs could be binding with higher affinity to the L-rhamnose-deficient Lm
cell wall, or ii) they could be crossing it at a faster pace, thus reaching the membrane more
quickly than in wild type Lm. To explore these possibilities, we first investigated the binding af-
finity of the mouse cathelicidin CRAMP towards Lm cell walls depleted of L-rhamnose. For
this, we incubated the different Lm strains with CRAMP for a short period and analyzed by
flow cytometry the amount of Lm-bound peptide exposed at the cell surface and accessible for
antibody recognition. We detected fluorescence associated with surface-exposed CRAMP in all
strains (Fig 4A). However, the mean fluorescence intensity (MFI) values were significantly
reduced in both ΔrmlACBD and ΔrmlTmutants, in comparison to wild type Lm and the com-
plemented strains (Fig 4A and 4B). This suggests that CRAMP was less accessible to immuno-
labeling at the cell surface of Lm lacking L-rhamnosylated WTAs.
The affinity of AMPs towards the bacterial surface is driven by electrostatic forces between
positively charged peptides and the anionic cell envelope [23]. To determine if variations of the
Lm surface charge contributed to the reduced amount of CRAMP exposed at the surface of
ΔrmlACBD and ΔrmlT bacteria, we compared the surface charge of Lm with or without
L-rhamnosylated WTAs. For this, we analyzed the binding of cytochrome c, a small protein
with positive charge at physiological conditions (isoelectric point ~10), to the wild type and
mutant Lm strains. As positive control, we used a mutant strain that cannot modify its LTAs
with D-alanine (ΔdltA) and, as a result, displays a higher surface electronegativity and a con-
comitant higher affinity for positively charged compounds [14, 47]. As expected, the level of cy-
tochrome c binding was higher with the ΔdltA strain than with the respective wild type strain,
as illustrated by a decreased percentage of unbound cytochrome c (Fig 4C). However, no signif-
icant difference in cytochrome c binding levels was observed between ΔrmlACBD, ΔrmlT and
wild type EGD-e strains (Fig 4C), indicating that the absence of L-rhamnose in WTAs does not
affect the Lm surface charge. This was further corroborated by zeta potential measurements
showing similar pH-dependent variations for both wild type and mutant strains (S5 Fig in S1
Text). Overall, these results allowed us to discard electrostatic changes as a reason behind the
difference in the levels of CRAMP detected at the Lm cell surface.
To further explore the decreased levels of surface-exposed CRAMP in Lm strains lacking L-
rhamnosylated WTAs, we compared total levels of bacterium-associated CRAMP in the differ-
ent strains by flow cytometry, following a short incubation with a fluorescently labeled form of
this AMP. The intensity of Lm-associated CRAMP fluorescence was comparable for the wild
type EGD-e, ΔrmlACBD and ΔrmlT strains (Fig 4D and 4E), indicating that the overall peptide
levels associated to Lm cells were similar between the different strains. Accordingly, the residu-
al fluorescence in the supernatants obtained by centrifugation of the bacteria-peptide suspen-
sions was also similar (Fig 4F). As positive control we used the ΔdltA strain, which displayed a
significantly stronger peptide binding than its parental wild type strain (Fig 4D–4F). These
data strongly suggest that the increased CRAMP susceptibility of Lm strains lacking L-rhamno-
sylated WTAs results from an improved penetration of CRAMP through their cell walls. Alto-
gether, these results showed that L-rhamnosylated WTAs do not interfere with the Lm surface
charge or with the binding efficiency of AMPs, but likely promote Lm survival by hindering
the crossing of its cell wall by these bactericidal molecules.
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WTA L-rhamnosylation delays AMP interaction with the Lm plasma
membrane
In light of these results, we then examined whether WTA L-rhamnosylation interfered with
the dynamics of AMP interaction with the Lm plasma membrane. We performed a time-course
study to follow Lmmembrane potential changes induced by CRAMP. In live bacteria, the
Fig 4. WTA l-rhamnosylation interferes with the Lm cell wall crossing by AMPs. (A and B) Flow cytometry analysis of Lm surface-exposed CRAMP
levels in mid-exponential-phase Lm strains, following incubation (5 min) in a 5-μg/ml solution of the peptide and immunolabeling with anti-CRAMP and Alexa
Fluor 488-conjugated antibodies. (A) Representative experiment showing overlaid histograms of CRAMP-treated (solid line) and untreated (dashed line)
samples, with mean fluorescence intensity (MFI) values from treated samples indicated by vertical dashed lines. (B) Mean±SD of the MFI values of CRAMP-
treated samples from three independent experiments. (C) Cell surface charge analysis of Lm strains deficient for WTA L-rhamnosylation as determined by
cytochrome c binding assays. Mid-exponential-phase bacteria were incubated with equine cytochrome c (0.5 mg/ml), centrifuged and the supernatant was
recovered for spectrophotometric quantification of the unbound protein fraction. Values from Lm-containing samples are expressed as the percentage of
unbound cytochrome c relative to control samples lacking bacteria. Data represent the mean±SD of three independent experiments. (D and E) Flow
cytometry analysis of total Lm-associated CRAMP levels in mid-exponential-phase Lm strains, following incubation (5 min) with a 5-μg/ml solution of
fluorescently labeled peptide (5-FAM-CRAMP). (D) Representative experiment showing overlaid histograms of FAM-CRAMP-treated (solid line) and
untreated (dashed line) samples, with MFI values from treated samples indicated by vertical dashed lines. (E) Mean±SD of the MFI values of
5-FAM-CRAMP-treated samples from three independent experiments. (F) Fluorometric quantification of the unbound CRAMP fraction in the supernatant of
suspensions of mid-exponential-phase Lm strains, following incubation (5 min) with a 5-μg/ml solution of 5-FAM-CRAMP. Data are expressed as the
percentage of unbound fluorescent peptide relative to control samples lacking bacteria, and represent the mean±SD of three independent experiments
performed in triplicates. ns = not significant, p>0.05; **, p0.01; ***, p0.001.
doi:10.1371/journal.ppat.1004919.g004
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membrane potential is an electric potential generated across the plasma membrane by the con-
centration gradients of sodium, potassium and chloride ions. Physical or chemical disruption
of the plasma membrane integrity leads to the suppression of this potential (depolarization)
[48]. Lm strains were incubated with DiOC2(3), a green fluorescent voltage-sensitive dye that
readily enters into bacterial cells. As the intracellular dye concentration increases with higher
membrane potential, it favors the formation of dye aggregates that shift the fluorescence emis-
sion to red. After stabilization of the DiOC2(3) fluorescence, CRAMP was added to bacterial
samples and the rate of Lm depolarization was immediately analyzed by measuring the red
fluorescence emission decline in a flow cytometer. The decrease in the membrane potential
was consistently greater in the ΔrmlACBD and ΔrmlT strains as compared to wild type Lm,
particularly in the first 10–15 min (Fig 5A), indicating that the Lm plasma membrane integrity
is compromised faster by the action of CRAMP in the absence of L-rhamnosylated WTAs. To
investigate if increased CRAMP-mediated disruption of the Lmmembrane integrity was asso-
ciated with increased permeabilization, we monitored in real time the entry of the fluorescent
probe SYTOX Green into the different Lm strains, following the addition of CRAMP. This
probe only enters into bacterial cells with a compromised membrane and displays a strong
green fluorescence emission after binding to nucleic acids. As expected, when CRAMP was
omitted from the bacterial suspensions, any increase in SYTOX Green-associated fluorescence
was detected (Fig 5B). However, in the presence of the peptide, the green fluorescence intensity
of samples containing the ΔrmlACBD or ΔrmlTmutants increased earlier than in samples con-
taining wild type Lm (Fig 5B), eventually reaching similar steady-state levels at later time points
(S7 Fig in S1 Text). These observations indicate that the CRAMP-mediated permeability in-
crease of the Lmmembrane to SYTOX Green occurs faster in strains lacking L-rhamnosylated
WTAs.
To investigate the ultrastructural localization of the peptide, we performed immunoelectron
microscopy on CRAMP-treated wild type and ΔrmlACBD Lm strains. Interestingly, CRAMP-
specific labeling was not only detected in the Lm cell envelope, as expected, but also in the cyto-
plasm (Fig 5C), suggesting that this AMP may additionally target components or processes in-
side Lm. Comparison of the subcellular distribution of CRAMP between these two bacterial
compartments revealed a preferential cell envelope localization in wild type Lm, which con-
trasted with the slight but significantly higher cytoplasmic localization of the peptide in the
ΔrmlACBD strain (Fig 5D). These observations are in agreement with a model in which
CRAMP crosses the Lm cell wall more efficiently in the absence of WTA L-rhamnosylation,
therefore reaching the bacterial membrane and the cytoplasm comparatively faster.
Finally, to confirm that the presence of L-rhamnosylated WTAs hinders the capacity of
AMPs to flow through the Lm cell wall, we assessed levels of CRAMP retained in purified cell
wall samples from the wild type, ΔrmlACBD and ΔrmlT strains by Western blot. After incuba-
tion with CRAMP, peptides trapped within the peptidoglycan matrix were released by mutano-
lysin treatment of the cell wall and quantitatively resolved by SDS-PAGE. Immunoblotting
revealed a small but consistent decrease in the amount of peptide associated with the cell wall
from the two mutant strains in comparison with wild type Lm (Fig 5E and 5F). This result indi-
cates that the lack of L-rhamnose in WTAs results in a partial loss of the AMP retention capaci-
ty of the Lm cell wall, which induces an enhanced AMP targeting of the Lm plasma membrane
and consequent bacterial killing.
All combined, these data support a model where the L-rhamnosylation of WTAs alters
the Lm cell wall permeability to favor the entrapment of AMPs. This obstructive effect hin-
ders AMP progression through the cell wall and delays their lethal interaction with the
plasma membrane.
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Fig 5. WTA l-rhamnosylation delays AMP interaction with the Lm plasmamembrane. (A) Depolarization rate of Lm strains in response to CRAMP. Mid-
exponential-phase bacteria pre-stained (15 min) with 30 μMDiOC2(3) were challenged with 50 μg/ml CRAMP and changes in the membrane potential,
expressed as the ratio of CRAMP-treated versus untreated samples, were monitored during 30 min. Data represent the mean±SD of three independent
experiments. (B) SYTOXGreen uptake kinetics of Lm strains in response to CRAMP-mediated membrane permeabilization. Exponential-phase bacteria
were incubated (37°C) with PBS (white symbols) or 50 μg/ml CRAMP (black symbols), in the presence of 1 μMSYTOXGreen, and the increase in green
fluorescence emission was recorded over time. (C and D) Transmission electron microscopy analysis of the subcellular distribution of CRAMP in
immunogold-labeled sections of mid-exponential-phase wild type and ΔrmlACBD Lm strains treated with 50 μg/ml CRAMP (15 min, 37°C). (C)
Representative images of contrasted sections of Lm cells showing CRAMP-specific gold labeling (10-nm black dots). Scale bar: 0.2 μm. (D) Quantification of
the subcellular partition of CRAMP labeling in wild type and ΔrmlACBD Lm strains, for two independent assays. The percentages of cell envelope- and
cytoplasm-associated gold dots per bacterium were quantified (at least 90 cells per strain) and the results expressed for each strain as mean±SD. (E and F)
Western blot analysis of levels of CRAMP bound to purified cell wall of different Lm strains. Purified cell wall (100 μg) was incubated with CRAMP (5 min),
washed and digested overnight with mutanolysin. (E) Supernatants frommutanolysin-treated samples were resolved in 16% Tris-tricine SDS-PAGE and
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WTA L-rhamnosylation is crucial for AMP resistance in vivo and Lm
virulence
To evaluate the importance of WTA L-rhamnosylation in Lm pathogenicity, we assessed the in
vivo virulence of Lm strains lacking L-rhamnosylatedWTAs. BALB/c mice were inoculated oral-
ly with wild type, ΔrmlACBD or ΔrmlT strains, and the bacterial load in the spleen and liver of
each animal was quantified three days later. The proliferative capacity of both ΔrmlACBD and
ΔrmlTmutant strains was similarly reduced in both organs, although more significantly in the
liver (Fig 6A and 6B). To determine if the decreased virulence of the mutant strains was due to a
specific defect in the crossing of the intestinal epithelium, BALB/c mice were challenged intrave-
nously, bypassing the intestinal barrier. Three days post-infection, the differences between mu-
tant and wild type strains, in both organs, were similar to those observed in orally infected
animals (Fig 6C and 6D), thus discarding any sieving effect of the intestinal epithelium on the
decreased splenic and hepatic colonization by both ΔrmlACBD and ΔrmlT. Importantly, organs
of mice infected intravenously with the complemented strains (ΔrmlACBD+rmlACBD and
ΔrmlT+rmlT) displayed bacterial loads comparable to wild type Lm-infected organs (Fig 6C and
6D). The attenuated in vivo phenotype of the ΔrmlACBD and ΔrmlT strains was not caused by
an intrinsic growth defect, as demonstrated by their wild type-like growth profiles in broth or
inside eukaryotic cells (S8 Fig in S1 Text). These results confirmed the involvement of the rml
operon in virulence, revealing a significant contribution of WTA L-rhamnosylation to Lm path-
ogenesis. Importantly, the in vivo attenuation of the ΔrmlT strain, which is unable to append
L-rhamnose to its WTAs but is able to synthesize the L-rhamnose precursor, showed that al-
though L-rhamnose biosynthesis is required to achieve optimal levels of virulence it is its cova-
lent linkage to theWTA backbone that is crucial for the successful Lm host infection.
To evaluate the protective role of WTA L-rhamnosylation against AMPs in vivo, we per-
formed virulence studies in a CRAMP-deficient mouse model. To determine the influence of
WTA L-rhamnosylation in Lm intestinal persistence, we performed oral infections of adult
CRAMP knockout 129/SvJ mice (cramp-/-, KO) [49] and of age- and background-matched
wild type mice (cramp+/+, WT), with the wild type or ΔrmlACBD Lm strains and monitored
the respective fecal carriage. In both WT and KOmice, we observed comparable dynamics of
fecal shedding of the wild type and ΔrmlACBD strains (Fig 6E and 6F). In agreement with the
comparable virulence defects observed for WTA L-rhamnosylation-deficient bacteria, follow-
ing oral or intravenous inoculation of BALB/c mice (Fig 6A–6D), these results suggest a minor
role for CRAMP in the control of Lm during the intestinal phase of the infection.
We then inoculated WT and KO mice intravenously and quantified bacterial numbers in
the spleen and liver, three days post-infection. In line with what was observed in BALB/c mice
(Fig 6C), the ΔrmlACBD strain showed significant virulence attenuation in both organs of
WT mice (Fig 6G). Interestingly, this virulence defect was nearly abolished in KO animals,
with the ΔrmlACBD strain displaying an organ-colonizing capacity similar to wild type bacte-
ria (Fig 6H). In addition, bacterial loads were higher in the organs of KO mice than in those of
WT animals (Fig 6G and 6H). These data indicate that, in comparison to their WT congeners,
KO mice are more susceptible to Lm infection, and confirm the in vivo listericidal activity of
CRAMP.
immunoblotted for CRAMP. The Lm cell wall-anchored protein InlA was used as loading control. (F) Quantification of the relative CRAMP levels represented
as the mean±SD of four independent blots. *, p0.05; **, p0.01.
doi:10.1371/journal.ppat.1004919.g005
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Fig 6. WTA l-rhamnosylation is necessary for AMP resistance in vivo and Lm virulence. (A–D)
Quantification of viable bacteria in the spleen and liver recovered from BALB/c mice (n = 5), three days after
(A and B) oral or (C and D) intravenous infection with sub-lethal doses of indicated Lm strains. Data are
presented as scatter plots, with each animal indicated by a dot and the mean indicated by a horizontal line. (E
and F) Quantification of the fecal shedding of wild type or ΔrmlACBD Lm strains after oral infection of (E) wild
type (WT, cramp+/+) and (F) CRAMP knockout (KO, cramp-/-) 129/SvJ mice (n = 5). Total feces produced by
each animal at specific time points were collected and processed for bacterial enumeration in Listeria-
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Altogether, these results highlight a key role for host-produced CRAMP in restraining Lm
infection and demonstrate that WTA L-rhamnosylation also promotes resistance to AMPs in
an in vivo context.
Discussion
Teichoic acids are key players in the maintenance of the Gram-positive cell envelope integrity
and functionality. They are typically decorated with D-alanine and/or a variety of glycosyl
groups, which influence the overall properties of these polymers [9]. Whereas D-alanylation of
WTAs has been demonstrated to contribute towards bacterial defense against AMPs [14, 23],
the involvement of glycosylation in this process has never been investigated. In this study, we
show for the first time that the glycosylation of LmWTAs with L-rhamnose is mediated by the
WTA L-rhamnosyltransferase RmlT and confers protection against AMPs in vitro and during
mouse infection. Based on our data, we propose that this protection results from a delayed tra-
versal of the Lm cell envelope by AMPs in the presence of L-rhamnose-decorated WTAs. Most
importantly, we reveal a key role for L-rhamnosylated WTAs in the processes underlying
Lm pathogenesis.
Unlike S. aureus or B. subtilis [22], WTAs in Listeria are not decorated with D-alanine, un-
dergoing only glycosylation with a small pool of monosaccharides [6, 10]. Among these is
L-rhamnose, which is the product of a remarkably conserved biosynthetic pathway that is en-
coded by the rmlABCD genes [35]. Interestingly, a significant number of bacteria harboring
these genes are commonly pathogenic [27–32] and have L-rhamnose in close association with
surface components [50, 51]. In Listeria, the rmlACBD locus is only found in certain serotypes
of Lm (1/2a, 1/2b, 1/2c, 3c and 7) and L. seeligeri (1/2b). These serotypes were all shown to
have L-rhamnose in their WTAs, except for Lm serotypes 3c and 7 [6], which appear to be un-
able to produce this sugar because of mutations within rmlA and rmlB, respectively (Fig 1).
Our results confirmed that the appendage of L-rhamnose to LmWTAs requires the products
of the rmlACBD locus. Ultimately, WTA glycosylation is catalyzed by glycosyltransferases, a
class of enzymes that recognize nucleotide-sugar substrates and transfer the glycosyl moiety
to a WTA subunit [52]. In silico analysis of lmo1080, the first gene of the operon including
rmlACBD (Fig 1) showed that it encodes a protein with putative glycosyltransferase activity.
The genomic location and predicted protein function were strong indicators that this gene
might encode the transferase involved in the L-rhamnosylation of LmWTAs. Our data dem-
onstrated that whereas lmo1080, that we renamed rmlT, is dispensable for rhamnose biosyn-
thesis, it is required for the addition of L-rhamnose to WTAs in Lm strains with a functional
L-rhamnose pathway, thus validating RmlT as the L-rhamnose-specific WTA glycosyltransfer-
ase in Lm.
WTAs are associated with the natural resistance of S. aureus to peptidoglycan-degrading en-
zymes, such as lysozyme [37, 41]. In contrast, absence of WTA decoration, but not of the poly-
mers, was shown to induce an increase of the staphylococcal susceptibility to lysostaphin [53].
Modifications of the Lm peptidoglycan, such as N-deacetylation [42], were found to contribute
to protection against lysozyme, but the role of WTAs and in particular their decoration, was
never addressed. Our results discard WTA L-rhamnosylation as a component of the Lm
selective agar media. Data are expressed as mean±SD. (G and H) Quantification of viable bacteria in
spleens and livers recovered from (G) wild type (WT, cramp+/+) and (H) CRAMP knockout (KO, cramp-/-) 129/
Sv mice (n = 5), three days after intravenous infection with sub-lethal doses of wild type or ΔrmlACBD Lm
strains. Data are presented as scatter plots, with each animal represented by a dot and the mean indicated by
a horizontal line. *, p0.05; **, p0.01; ***, p0.001.
doi:10.1371/journal.ppat.1004919.g006
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resistance mechanism to this host immune defense protein, as well as its involvement in the
promotion of growth under osmotic conditions. Other innate immune effectors, such as anti-
microbial peptides (AMPs), also target bacterial organisms [54] that in turn have developed re-
sistance strategies to avoid injury and killing induced by AMPs. Among these strategies is the
reshaping and fine-tuning of cell envelope components to lower AMP affinity to the bacterial
surface [21]. Previous studies showed a clear link between the D-alanylation of WTAs and
AMP resistance [14, 43]. In this context, we found here a similar role for WTA L-rhamnosyla-
tion, showing that, in the absence of L-rhamnosylated WTAs, bacteria exhibit an increased sus-
ceptibility to AMPs produced by bacteria, mice and importantly by humans. Although from
such distinct sources, AMPs used here share a cationic nature that supports their activity. How-
ever, while teichoic acid D-alanylation is known to reduce the cell wall electronegativity [14],
glycosyl substituents of LmWTAs are neutrally charged andWTA glycosylation should thus
promote AMP resistance through a different mechanism.
It is well established that AMPs induce bacterial death mainly by tampering with the integri-
ty of the plasma membrane. This can be achieved through multiple ways, all of which are driv-
en by the intrinsic amphipathic properties of this class of peptides [55]. Nonetheless, the initial
interaction of AMPs with bacterial surfaces is mediated by electrostatic forces between their
positive net charge and the anionic cell envelope [23]. Our data show that, unlike D-alanylation
[56], WTA L-rhamnosylation does not interfere with the Lm cell surface charge, in agreement
with L-rhamnose being an electrostatically neutral monosaccharide. Importantly, the reduced
levels of surface-exposed CRAMP in Lm strains lacking L-rhamnosylated WTAs suggested in-
stead that their increased susceptibility to this peptide was correlated with its improved pene-
tration of the L-rhamnose-depleted Lm cell wall. We confirmed this premise with data showing
that CRAMP-mediated cell depolarization and plasma membrane permeabilization events
occur earlier in WTA L-rhamnosylation-deficient Lm strains. In addition, we also observed a
predominant cytoplasmic presence of CRAMP in these mutant strains, in contrast to the pref-
erential cell envelope localization in wild type Lm, further suggesting a WTA L-rhamnosyla-
tion-dependent kinetic discrepancy in the progression of CRAMP through the Lm cell
envelope. Saar-Dover et al. demonstrated in the WTA-lacking Streptococcus agalactiae (GBS)
that LTA D-alanylation promoted resistance to the human cathelicidin LL-37 by hindering cell
wall crossing and plasma membrane disturbance [57]. They proposed that the underlying
mechanism does not rely on modulation of the surface charge but on LTA conformation-asso-
ciated alterations of the cell wall packing density [57]. Our data are in line with these observa-
tions and although we did not detect changes in the cell wall cross-linking status, we cannot
ignore a possible impact of L-rhamnosylation onWTA polymer conformation accounting for
changes in cell wall permeability. If one considers that the peptidoglycan, a multi-layered and
compact structure, is densely populated with WTA polymers decorated with multiple units of
the rather bulky L-rhamnose molecule, spatial constraints and increased cell wall density need
to be accounted. In fact, we showed that purified Lm cell wall depleted of L-rhamnose does not
retain CRAMP in its peptidoglycan matrix as effectively as cell wall containing L-rhamnosy-
lated WTAs. In addition, we have indications that soluble L-rhamnose interferes with CRAMP
activity, improving the survival of WTA L-rhamnosylation mutants of Lm. These observations
suggest a potential interaction between L-rhamnose and AMPs, which could favor the “retarda-
tion effect” that ultimately promotes Lm survival.
We previously reported a significantly increased transcription of rmlACBD during mouse
spleen infection [24], which suggested that WTA L-rhamnosylation is highly activated by Lm
to successfully infect this host organ. Our infection studies in mice confirmed the importance
of this mechanism for Lm pathogenesis by revealing a significant virulence attenuation of
WTA L-rhamnosylation-deficient Lm strains. Surprisingly, the expression of rmlT appeared
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unchanged during mouse spleen infection as compared to growth in BHI [24], suggesting that
an increased L-rhamnose biosynthesis could be sufficient to induce an increased WTA L-rham-
nosylation and AMP resistance. Faith et al. also observed a decreased bacterial burden of a se-
rotype 4b Lm strain lacking the gtcA gene [58], a mutation that resulted in complete loss of
galactose decoration of its WTAs [59]. Interestingly, gtcA is also present in Lm EGD-e, where it
appears to be involved in WTA substitution with N-acetylglucosamine [60], and was shown to
contribute to the colonization of the mouse spleen, liver and brain [61]. However the mecha-
nism through which this occurs remains unclear.
Virulence studies in mice lacking the CRAMP gene corroborated our in vitro susceptibility
data and revealed the importance of WTA L-rhamnosylation-promoted resistance to AMPs
for Listeria virulence. In vivo data also provided a strong insight into the protective role of
CRAMP against systemic infection by Lm, as had been previously observed with other bacterial
pathogens [49, 62, 63]. Our results on fecal shedding dynamics suggest that the contribution of
CRAMP to the control of Lm during the intestinal phase of infection is minimal. A previous re-
port showed a negligible enteric secretion of CRAMP in normal adult mice [64], which may ex-
plain the similar shedding behavior of the wild type and ΔrmlACBD strains that were observed
in both mouse strains. In this scenario, infection studies in newborn animals, whose entero-
cytes actively express CRAMP [45, 64], may provide conclusive information regarding the role
of WTA L-rhamnosylation in the Lm resistance to CRAMP during the intestinal phase of the
infection. Notwithstanding, CRAMP is actively produced by phagocytes in adult mice [65]. As
a major target for Lm colonization, the spleen is also an important reservoir of phagocytic cells.
We can speculate that WTA L-rhamnosylation is particularly important to increase the chances
of Lm surviving CRAMP-mediated killing during spleen infection. Considering our data on
the Lm susceptibility to LL-37, the human homolog of CRAMP, we can also envisage this sce-
nario in the context of human infection.
In conclusion, our work has unveiled for the first time a role for WTA glycosylation in bac-
terial resistance to AMPs. We propose that WTA L-rhamnosylation reduces the cell wall per-
meability to AMPs, promoting a delay in the crossing of this barrier and in the disruption of
the plasma membrane, thus favoring Lm survival and virulence in vivo. Our findings reveal a
novel facet in the contribution of WTA modifications towards AMP resistance, reinforcing the
crucial role of these Gram-positive surface glycopolymers in host defense evasion.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1. Lm and E. coli strains were routinely
cultured aerobically at 37°C in brain heart infusion (BHI, Difco) and Lysogeny Broth (LB)
media, respectively, with shaking. For experiments involving the Lm ΔtagO1ΔtagO2 strain,
bacteria were first cultured overnight at 30°C with shaking in the presence of 1 mM IPTG (iso-
propyl-β-D-thiogalactopyranoside), washed and diluted (1:100) in fresh BHI and cultured over-
night at 30°C with shaking [36]. When appropriate, the following antibiotics were included in
culture media as selective agents: ampicilin (Amp), 100 μg/ml; chloramphenicol (Cm), 7 μg/ml
(Lm) or 20 μg/ml (E. coli); erythromycin (Ery), 5 μg/ml. For genetic complementation pur-
poses, colistin sulfate (Col) and nalidixic acid (Nax) were used at 10 and 50 μg/ml, respectively.
Construction and complementation of mutant strains
Lmmutant strains were constructed in the EGD-e background through a process of double ho-
mologous recombination mediated by the suicide plasmid pMAD [66]. DNA fragments corre-
sponding to the 5’- and 3’-flanking regions of the rmlACBD locus (lmo1081—4) were amplified
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by PCR from Lm EGD-e chromosomal DNA with primers 1–2 and 3–4 (S2 Table in S1 Text),
and cloned between the SalI—MluI andMluI—BglII sites of pMAD, yielding pDC303. Similar-
ly, DNA fragments corresponding to the 5’- and 3’-flanking regions of rmlT (lmo1080) were
amplified with primers 15–16 and 17–18 (S2 Table in S1 Text), and cloned between the SalI—
EcoRI and EcoRI—BglII sites of pMAD, yielding pDC491. The plasmid constructs were intro-
duced in Lm EGD-e by electroporation and transformants selected at 30°C in BHI—Ery. Posi-
tive clones were re-isolated in the same medium and grown overnight at 43°C. Integrant clones
were inoculated in BHI broth and grown overnight at 30°C, after which the cultures were seri-
ally diluted, plated in BHI agar and incubated overnight at 37°C. Individual colonies were test-
ed for growth in BHI—Ery at 30°C and antibiotic-sensitive clones were screened by PCR for
deletion of rmlACBD (primers 5–6, 7–8, 9–10 and 11–12) and rmlT (primers 19–20) (S2
Table in S1 Text). Genetic complementation of the deletion mutant strains was performed as
described [24]. DNA fragments containing either the rmlACBD or rmlT loci were amplified
from Lm EGD-e chromosomal DNA with primers 13–14 and 21–22 (S2 Table in S1 Text), re-
spectively, and cloned between the SalI—PstI sites of the phage-derived integrative plasmid
pPL2 [67], generating pDC313 and pDC550. The plasmid constructs were introduced in the E.
coli strain S17-1 and transferred, respectively, to the ΔrmlACBD and ΔrmlT strains by conjuga-
tion on BHI agar. Transconjugant clones were selected in BHI—Cm/Col/Nax and chromosom-
al integration of the plasmids confirmed by PCR with primers 23 and 24 (S2 Table in S1 Text).
All plasmid constructs and gene deletions were confirmed by DNA sequencing.
Table 1. Plasmids and bacterial strains.
Plasmid or strain Code Relevant characteristics Source
Plasmids
pMAD Gram-negative/Gram-positive shuttle vector; thermosensitive replication; Ampr Eryr [66]
pPL2 L. monocytogenes phage-derived site-specific integration vector; Cmr [67]
pMAD(ΔrmlACBD) pDC303 pMAD with 5’- and 3’-flanking regions of rmlACBD locus; Ampr Eryr This study
pPL2(rmlACBD) pDC313 pPL2 with rmlACBD locus and 5’- and 3’-flanking regions; Cmr This study
pMAD(ΔrmlACBD) pDC491 pMAD with 5’- and 3’-flanking regions of rmlT; Ampr Eryr This study
pPL2(rmlT) pDC550 pPL2 with rmlT sequence and 5’- and 3’-flanking regions; Cmr This study
E. coli strains
DH5α Cloning host strain; F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk
-, mk
+)
phoA supE44 thi-1 gyrA96 relA1 λ-
Life
Technologies
S17-1 Conjugative donor strain; recA pro hsdR RP4-2-Tc::Mu-Km::Tn7 [77]
L. monocytogenes strains
EGD-e wild type; serotype 1/2a [78]
EGD-e ΔpgdA EGD-e pgdA (lmo0415) deletion mutant [42]
EGD-e ΔrmlACBD DC307 EGD-e rmlACBD (lmo1081–4) deletion mutant This study
EGD-e ΔrmlACBD::pPL2
(rmlACBD)
DC367 EGD-e rmlACBD (lmo1081–4) deletion mutant complemented with pPL2(rmlACBD)
(pDC313); Cmr
This study
EGD-e ΔrmlT DC492 EGD-e rmlT (lmo1080) deletion mutant This study
EGD-e ΔrmlT::pPL2(rmlT) DC553 EGD-e rmlT (lmo1080) deletion mutant complemented with pPL2(rmlT) (pDC550); Cmr This study
EGD-e ΔtagO1ΔtagO2::
pLIV2(tagO1)
EGD-e tagO1 (lmo0959) and tagO2 (lmo2519) double deletion mutant complemented with
pLIV2(tagO1), expressing tagO1 under the control of an IPTG-inducible promoter; Cmr
[36]
EGD BUG600 wild type; serotype 1/2a [79]
EGD ΔdltA BUG2182 EGD dltA (LMON_0982) deletion mutant [80]
doi:10.1371/journal.ppat.1004919.t001
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Gene expression analyses
Total bacterial RNA was isolated from 10 ml of exponential cultures (OD600 = 0.6) by the phe-
nol-chloroform extraction method, as previously described [68], and treated with DNase I
(Turbo DNA-free, Ambion), as recommended by the manufacturer. Purified RNAs (1 μg)
were reverse-transcribed with random hexamers, using iScript cDNA Synthesis kit (Bio-Rad
Laboratories). Quantitative real-time PCR (qPCR) was performed in 20-μl reactions containing
2 μl of cDNA, 10 μl of SYBR Green Supermix (Bio-Rad Laboratories) and 0.25 μM of forward
and reverse primers (S2 Table in S1 Text), using the following cycling protocol: 1cycle at 95°C
(3 min) and 40 cycles at 95°C (30 s), 55°C (30 s) and 72°C (30 s). Each target gene was analyzed
in triplicate and blank (water) and DNA contamination controls (unconverted DNase I-treated
RNA) were included for each primer pair. Amplification data were analyzed by the compara-
tive threshold (ΔΔCt) method, after normalization of the test and control sample expression
values to a housekeeping gene (16S rRNA). For qualitative analysis, PCR was performed in 20-
μl reactions containing 2 μl of cDNA, 10 μl of MangoMix 2× reaction mix (Bioline) and 0.5 μM
of forward and reverse qPCR primers, using the following protocol: 1 cycle at 95°C (5 min), 25
cycles at 95°C (30 s), 55°C (30 s) and 72°C (20 s), and 1 cycle at 72°C (5 min). Amplification
products were resolved in 1% (w/v) agarose gel and analyzed in a GelDoc XR+ System (Bio-
Rad Laboratories).
WTA PAGE analysis
Extraction and analysis of LmWTAs by polyacrylamide gel electrophoresis was performed es-
sentially as described [69], with the exception that WTAs extracts were obtained from expo-
nential-phase cultures. Sedimented bacteria were washed (buffer 1: 50 mMMES buffer, pH
6.5) and boiled for 1 h (buffer 2: 4% SDS in buffer 1). After centrifugation, the pellet was serially
washed with buffer 2, buffer 3 (2% NaCl in buffer 1) and buffer 1, before treatment with 20 μg/
ml proteinase K (20 mM Tris-HCl, pH 8; 0.5% SDS) at 50°C for 4 h. The digested samples were
thoroughly washed with buffer 3 and distilled water and incubated overnight (16 h) with 0.1 M
NaOH, under vigorous agitation. Cell wall debris were removed by centrifugation (10,000 rpm,
10 min) and the hydrolyzed WTAs present in the supernatant were directly analyzed by native
PAGE in a Tris-tricine buffer system. WTA extracts were resolved through a vertical (20 cm)
polyacrylamide (20%) gel at 20 mA for 18 h (4°C). To visualize WTAs, the gel was stained in
0.1% Alcian blue (40% ethanol; 5% acetic acid) for 30 min and washed (40% ethanol; 10% ace-
tic acid) until the background is fully cleared. Optionally, for increased contrasting, silver stain-
ing can be performed on top of the Alcian blue staining.
Purification of cell wall components
Cell walls of Lm strains were purified as described before [70], with modifications. Overnight
cultures were subcultured into 1–2 liters of BHI broth (initial OD600 = 0.005) and bacteria
grown until exponential phase (OD600 = 1.0–1.5). Cultures were rapidly cooled in an ice/etha-
nol bath and bacteria harvested by centrifugation (7,500 rpm, 15 min, 4°C). The pellet was re-
suspended in cold ultrapure water and boiled for 30 min with 4% SDS to kill bacteria and
inactivate cell wall-modifying enzymes. The samples were cleared of SDS by successive cycles
of centrifugation (12,000 rpm, 10 min) and washing with warm ultrapure water until no deter-
gent was detected [71]. SDS-free samples were resuspended in 2 ml of ultrapure water and cell
walls disrupted with glass beads in a homogenizer (FastPrep, Thermo Savant). Fully broken
cell walls were separated from glass beads by filtration (glass filters, pore size: 16–40 μm) and
from unbroken cell walls and other debris by low-speed centrifugation (2,000 rpm, 15 min).
Nucleic acids were degraded after incubation (2 h) at 37°C with DNase (10 μg/ml) and RNase
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(50 μg/ml) in a buffer containing 50 mM Tris-HCl, pH 7.0, and 20 mMMgSO4. Proteins were
then digested overnight at 37°C with trypsin (100 μg/ml) in the presence of 10 mM CaCl2. Nu-
clease and proteases were inactivated by boiling in 1% SDS, and samples were centrifuged
(17,000 rpm, 15 min) and washed twice with ultrapure water. Cell walls were resuspended and
incubated (37°C, 15 min) in 8 M LiCl and then in 100 mM EDTA, pH 7.0, after which they
were washed twice with water. After resuspension in acetone and sonication (15 min), cell
walls were washed and resuspended in ultrapure water before undergoing lyophilization.
To obtain purified peptidoglycan, cell walls (20 mg) were incubated for 48 h with 4 ml of
46% hydrofluoric acid (HF), under agitation at 4°C. Samples were washed with 100 mM Tris-
HCl, pH 7.0, and centrifuged (17,000 rpm, 30 min, 4°C) as many times as necessary to neutral-
ize the pH. The pellet was finally washed twice with water prior to lyophilization. WTA extracts
were obtained by incubating 1 mg of cell wall with 300 μl of 46% HF (18 h, 4°C). After centrifu-
gation (13,200 rpm, 15 min, 4°C), the supernatant was recovered and evaporated under a
stream of compressed air. The dried WTA residue was resuspended in water and lyophilized.
Extraction of bacterial cytoplasmic content
The intracellular content of Lm strains was isolated according to a modified version of the pro-
tocol by Ornelas-Soares et al. [72]. Bacterial cultures (200 ml) were grown until early exponen-
tial phase (OD600 = 0.3), and vancomycin was added at 7.5 μg/ml (5×MIC value [73]) to
induce the cytoplasmic accumulation of the peptidoglycan precursor UDP-MurNAc-penta-
peptide. Cultures were grown for another 45 min and chilled in an ice-ethanol bath for 10 min.
Bacteria were then harvested by centrifugation (12,000 rpm, 10 min, 4°C), washed with cold
0.9% NaCl, resuspended in 5 ml of cold 5% trichloroacetic acid and incubated for 30 min on
ice. Cells and other debris were separated by centrifugation (4,000 rpm, 15 min, 4°C) and the
supernatant was extracted with 1–2 volumes of diethyl ether as many times as necessary to re-
move TCA (sample pH should rise to at least 6.0). The aqueous fraction containing the cyto-
plasmic material was lyophilized and the dried residue resuspended in ultrapure water.
HPLC analyses
To analyze their sugar composition, purified cell wall and peptidoglycan (200 μg each), as well
as cytoplasmic (500 μg) andWTA extracts were hydrolyzed in 3 M HCl for 2 h at 95°C. After
vacuum evaporation, the samples were washed with water and lyophilized. The hydrolyzed ma-
terial was then resuspended in 150 μl of water and resolved by high-performance anion-ex-
change chromatography coupled with pulsed amperometric detection (HPAEC-PAD). Ten
microliters were injected into a CarboPac PA10 column (Dionex, Thermo Fisher Scientific)
and eluted at 1 ml/min (30°C) with 18 mMNaOH, followed by a gradient of NaCH3COO:
0–20 mM (t = 25–30 min), 20–80 mM (t = 30–35 min), 80–0 mM (t = 40–45 min). Standards
for glucosamine, muramic acid, L-rhamnose and ribitol (Sigma-Aldrich) were eluted under the
same conditions to enable identification of chromatogram peaks. Data were acquired and ana-
lyzed with the Chromeleon software (Dionex, Thermo Fisher Scientific).
Muropeptide samples were prepared and analyzed as described [74], with minor changes.
Purified peptidoglycan was digested with 200 μg/ml mutanolysin (Sigma-Aldrich) in 12.5 mM
sodium phosphate, pH 5.5, for 16 h at 37°C. Enzymatic activity was halted by heating at 100°C
for 5 min, after which the digested sample was reduced for 2 h with 2.5 mg/ml of sodium boro-
hydride (NaBH4) in 0.25 M borate buffer, pH 9.0. The reaction was stopped by lowering the
sample pH to 2 with ortho-phosphoric acid. After centrifugation, the supernatant was analyzed
by reverse phase HPLC. Fifty microliters were injected into a Hypersil ODS (C18) column
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(Thermo Fisher Scientific) and muropeptide species eluted (0.5 ml/min, 52°C) in 0.1 M sodium
phosphate, pH 2.0, with a gradient of 5–30% methanol and detected at 206 nm.
Intracellular multiplication
Mouse macrophage-like J774A.1 cells (ATCC, TIB-67) were propagated in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 10% fetal bovine serum and infection assays were
performed as described [24]. Briefly, cells (~2×105/well) were infected for 45 min with expo-
nential-phase bacteria at a multiplicity of infection of ~10 and treated afterwards with 20 μg/ml
gentamicin for 75 min. At several time-points post-infection, cells were washed with PBS and
lysed in cold 0.2% Triton X-100 for quantification of viable intracellular bacteria in BHI agar.
One experiment was performed with triplicates for each strain and time-point.
Resistance to salt stress and lysozyme
Lm cultures grown overnight were appropriately diluted in BHI broth and their growth under
the presence of stressful stimuli was monitored by optical density measurement at 600 nm
(OD600). For comparative analysis of Lm resistance to salt stress, bacterial cultures were diluted
100-fold in BHI alone (control) or BHI containing 5% NaCl. To assess the Lm resistance to ly-
sozyme, exponential-phase cultures (OD600 1.0) were challenged with different doses of
chicken egg white lysozyme (Sigma). A mutant Lm strain hypersensitive to lysozyme (ΔpgdA)
was used as a positive control for susceptibility.
AMP susceptibility
Bacteria in the exponential phase of growth (OD600 = 0.7–0.8) were diluted (10
4 CFU/ml) in
sterile PB medium (10 mM phosphate buffer, pH 7.4; 1% BHI) and mixed in a 96-well micro-
plate with increasing concentrations of gallidermin (Santa Cruz Biotechnology), CRAMP or
LL-37 (AnaSpec). Bacterial suspensions without AMPs were used as reference controls for op-
timal growth/survival. After incubation for 2 h at 37°C, the mixtures were serially diluted in
sterile PBS and plated in BHI agar for quantification of viable bacteria. Each condition was ana-
lyzed in duplicate in three independent assays.
Cytochrome c binding
Cytochrome c binding assays were performed as described [56]. Bacteria from mid-exponen-
tial-phase cultures (OD600 = 0.6–0.7) were washed in 20 mMMOPS buffer, pH 7.0, and re-
suspended in ½ volume of 0.5 mg/ml equine cytochrome c (Sigma-Aldrich) in 20 mMMOPS
buffer, pH 7.0. After 10 min of incubation, bacteria were pelleted and the supernatant collect-
ed for quantification of the absorbance at 530 nm. The mean absorbance values from repli-
cate samples containing bacteria were subtracted to the mean value of a reference sample
lacking bacteria, and the results were presented for each strain as percentage of unbound
cytochrome c.
Zeta potential measurements
Bacteria (1 ml) from mid-exponential-phase cultures were washed twice with deionized water
and diluted (107 CFU/ml) in 15 mMNaCl solutions adjusted to different pH values (1 to 7)
with nitric acid. Bacterial suspensions (750 μl) were injected into a disposable capillary cell
cuvette (DTS1061, Malvern Instruments) and the zeta potential was measured at 37°C in a
ZetaSizer Nano ZS (Malvern Instruments), under an automated field voltage. Samples were
measured in triplicate in three independent assays.
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Flow cytometry analyses
Bacteria from 500 μl of mid-exponential-phase cultures were washed twice with PBS and treat-
ed for 5 min with 5 μg/ml CRAMP or PBS (untreated control). After centrifugation, the super-
natant was removed and PBS-washed bacteria were incubated for 1 h with rabbit anti-CRAMP
(1:100, Innovagen), followed by 1 h with Alexa Fluor 488-conjugated anti-rabbit IgG (1:200,
Molecular Probes). Finally, bacteria were fixed with 3% paraformaldehyde for 15 min, washed
and resuspended in PBS. Alternatively, bacteria were similarly treated with an N-terminally
5-FAM-labeled synthetic form of CRAMP (95% purity, Innovagen), washed and resuspended
in PBS. Samples were acquired in a FACSCalibur flow cytometer equipped with CellQuest soft-
ware (BD Biosciences) and data were analyzed with FlowJo (TreeStar Inc.). Green fluorescence
was collected from at least 50,000 FSC/SSC-gated bacterial events in the FL1 channel (530 nm/
20 nm bandpass filter). Fluorescence intensities were plotted in single-parameter histograms
and results were presented as the average mean fluorescence intensity (MFI) value from three
independent analyses.
For bacterial membrane potential studies, the lipophilic fluorescent probe DiOC2(3)
(3,3-diethyloxacarbocyanine, Santa Cruz Biotechnology) was used as a membrane potential in-
dicator [48, 75]. Mid-logarithmic phase bacteria were diluted (106 CFU/ml) in PBS with 30 μM
DiOC2(3) and incubated for 15 min in the dark. CRAMP was added to a final concentration of
50 μg/ml and the sample was immediately injected in the flow cytometer. Control samples
treated with PBS or with 1.5 mM sodium azide (uncoupling agent) were analyzed to determine
the fluorescence values corresponding to basal (100%) and null (0%) membrane potential (S6
Fig in S1 Text). Green and red (FL3, 670 nm/long bandpass filter) fluorescence emissions were
continuously collected from FSC/SSC-gated bacteria for 30 min. After acquisition, a ratio of
red over green fluorescence (R/G) was calculated per event and plotted in the y-axis versus
time. A series of consecutive one-minute-wide gates was applied to the plot and the mean R/G
value per gate was determined. The mean R/G values from uncoupler-treated samples were de-
ducted from the corresponding values from the untreated and CRAMP-treated samples, and
the resulting values for each condition were normalized as percentage of the initial value (t = 1
min). Finally, the temporal variation of the Lmmembrane potential was represented graphical-
ly as the ratio of the normalized values from CRAMP-treated over untreated samples.
SYTOX Green uptake
Bacterial uptake of the cell-impermeable SYTOX Green dye was used to study membrane per-
meabilization induced by CRAMP [57]. Exponential-phase bacteria were washed and resus-
pended (107 CFU/ml) in sterile PBS containing 1 μM SYTOX Green (Molecular Probes). After
20 min of incubation in the dark, bacterial suspensions were mixed in PCR microplate wells
with 50 μg/ml CRAMP or PBS (negative control) for a total volume of 100 μl. The mixtures
were immediately placed at 37°C in a real-time PCR detection system (iQ5, Bio-Rad Laborato-
ries) and fluorescence emission at 530 nm was recorded every minute following excitation at
488 nm.
Binding of AMP to purified cell walls
One-hundred micrograms of purified cell wall were resuspended in 50 μl of 5 μg/ml CRAMP
or PBS (negative control) and gently shaken for 5 min. Samples were centrifuged (16,000 × g, 1
min), washed in PBS and in TM buffer (10 mM Tris-HCl, 10 mMMgCl2, pH 7.4) before over-
night incubation at 37°C with mutanolysin (400 U/ml) in TM buffer (50 μl). Supernatants were
resolved by tricine-SDS-PAGE in a 16% gel, transferred onto nitrocellulose membrane and
blotted with rabbit anti-CRAMP (1:1000) or mouse anti-InlA (L7.7; 1:1000), followed by
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HRP-conjugated goat anti-rabbit or anti-mouse IgG (1:2000, P.A.R.I.S). Immunolabeled bands
were visualized using SuperSignal West Dura Extended Duration Substrate (Pierce) and digi-
tally acquired in a ChemiDoc XRS+ system (Bio-Rad Laboratories).
Immunoelectron microscopy
Exponential-phase bacteria treated with 50 μg/ml CRAMP for 15 min at 37°C were fixed for 1
h at room temperature (4% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M sodium cacodylate,
pH 7.2), stained with 1% osmium tetroxide for 2 h and resuspended in 30% BSA (high-purity
grade). Bacterial pellets obtained after centrifugation in microhematocrit tubes were fixed over-
night in 1% glutaraldehyde, dehydrated in increasing ethanol concentrations, and embedded in
Epon 812. Ultrathin sections (40–50 nm) were placed on 400-mesh Formvar-coated copper
grids and treated with 4% sodium metaperiodate and 1% periodic acid (10 min each) for anti-
gen retrieval. For immunogold labeling of CRAMP, sections were blocked for 10 min with 1%
BSA and incubated overnight (4°C) with rabbit anti-CRAMP (1:100 in 1% BSA). After exten-
sive washing, sections were labeled with 10-nm gold complex-conjugated anti-rabbit IgG
(1:200 in 1% BSA) for 2 h, washed and contrasted with 4% uranyl acetate and 1% lead citrate.
Images were acquired in a Jeol JEM-1400 transmission electron microscope equipped with a
Gatan Orius SC1000 CCD camera and analyzed using ImageJ software.
Animal infections
Virulence studies were done in mouse models of the following strains: wild type BALB/c and
129/SvJ (Charles River Laboratories); and CRAMP-deficient (cramp-/-) 129/SvJ, which was
bred in our facilities from a breeding pair provided by Dr. Richard L. Gallo (University of Cali-
fornia, USA) [49]. Infections were performed in six-to-eight week-old specific-pathogen-free
females as described [76]. Briefly, for oral infections, 12-h starved animals were inoculated by
gavage with 109 CFU in PBS containing 150 mg/ml CaCO3, while intravenous infections were
performed through the tail vein with 104 CFU in PBS. In both cases, the infection was carried
out for 72 h, at which point the animals were euthanatized by general anesthesia. The spleen
and liver were aseptically collected, homogenized in sterile PBS, and serial dilutions of the
organ homogenates plated in BHI agar. For analysis of Lm fecal carriage, total feces produced
by each infected animal (n = 5 per strain) up to a given time-point were collected, homogenized
in PBS and serial dilutions plated in Listeria selective media (Oxoid) for bacterial enumeration.
Mice were maintained at the IBMC animal facilities, in high efficiency particulate air (HEPA)
filter-bearing cages under 12 h light cycles, and were given sterile chow and autoclaved water
ad libitum.
Ethics statement
All the animal procedures were in agreement with the guidelines of the European Commission
for the handling of laboratory animals (directive 2010/63/EU), with the Portuguese legislation
for the use of animals for scientific purposes (Decreto-Lei 113/2013), and were approved by the
IBMC Animal Ethics Committee, as well as by the Direcção Geral de Veterinária, the Portu-
guese authority for animal protection, under license PTDC/SAU-MIC/111581/2009.
Statistical analyses
Statistical analyses were performed with Prism 6 (GraphPad Software). Unpaired two-tailed
Student’s t-test was used to compare the means of two groups; one-way ANOVA was used
with Tukey’s post-hoc test for pairwise comparison of means from more than two groups, or
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with Dunnett’s post-hoc test for comparison of means relative to the mean of a control group.
Mean differences were considered statistically non-significant (ns) when p value was above
0.05. For statistically significant differences: , p0.05; , p0.01; , p0.001.
Supporting Information
S1 Text. Supporting figures and tables. S1 Fig Proteins involved in LmWTA L-rhamnosyla-
tion. (A) Schematic diagram of the L-rhamnose biosynthesis pathway (adapted from [31, 35]).
Each of the RmlACBD proteins catalyzes one of the four reaction steps that convert glucose-
1-phosphate into nucleotide-linked L-rhamnose. dTTP, thymidine triphosphate; PPi, pyro-
phosphate; NADP, nicotinamide adenine dinucleotide phosphate. (B) Alignment of the amino
acid sequences of B. subtilis 168 GgaB (GenBank: AAA73513.1) and Lm RmlT (GenBank:
NP_464605.1). Boxed sequences correspond to the GT-A glycosyltransferase fold domain, as
predicted by the NCBI Conserved Domain Search. The GT-A family signature DxD motif is
highlighted in dark gray. The numbers indicate the position of the last amino acid in each line.
Protein sequence alignments were obtained with ClustalW2 and edited with UCSF Chimera.
S2 Fig Genetic characterization of Lm strains used in this study. (A) Genotypes and gene ex-
pression of the constructed Lm strains were confirmed by PCR and RT-PCR. (B) Comparison
of the rmlACBD transcription levels in ΔrmlT versus wild type Lm strains by quantitative real-
time PCR. Data represent the mean±SD of three independent analyses. , p0.05. S3 Fig
HPLC analyses of the cell wall sugar and muropeptide composition from Lm strains. (A)
HPAEC-PAD analysis of the sugar composition of cell wall purified from Lm strains. Samples
were hydrolyzed in 3 M HCl (2 h, 95°C), diluted with water and lyophilized before injection
into the HPLC equipment. Standards for ribitol (Rib), L-rhamnose (Rha), glucosamine (GlcN),
and muramic acid (Mur) were eluted under identical conditions to allow peak identification.
(B) Reverse-phase HPLC analysis of the muropeptide composition from different Lm strains,
following overnight digestion of purified peptidoglycan samples with mutanolysin and reduc-
tion with NaBH4. Muropeptide species (monomeric, dimeric, trimeric, etc.) were eluted with a
5–30% methanol gradient and detected by UV absorption at 206 nm. S4 Fig Dose-dependent
survival response of Lm strains to different AMPs. Quantification of viable bacteria after
treatment of mid-exponential-phase Lm strains (2 h, 37°C) with increasing concentrations of
gallidermin, CRAMP or LL-37. The average replicate values from AMP-treated samples were
expressed as percentage of surviving bacteria relative to the values of the respective untreated
control samples (set at 100). Data represent mean±SD of three independent experiments. As-
terisks indicate statistical significance between wild type and mutant strains (, p0.05; ,
p0.001), while hashes indicate statistical significance between mutant and respective comple-
mented strains (#, p0.05; ###, p0.001). S5 Fig Zeta potential profile of wild type and
WTA L-rhamnosylation mutant Lm strains. S6 Fig Determination of the Lmmembrane po-
tential magnitude by flow cytometry. The membrane potential of untreated and sodium azide
(1.5 mM)-treated suspensions of DiOC2(3)-stained wild type EGD-e suspensions was analyzed
(see Materials and Methods) to determine the red/green fluorescence ratio values correspond-
ing, respectively, to a basal (100%) and null (0%) membrane potential. S7 Fig SYTOX Green
uptake kinetics of Lm strains in response to CRAMP-mediated membrane permeabiliza-
tion. Exponential-phase bacteria were incubated (37°C) with PBS (white symbols) or 50 μg/ml
CRAMP (black symbols), in the presence of 1 μM SYTOX Green, and the increase in green
fluorescence emission was recorded over 115 min. S8 Fig Growth of Lm strains in broth and
inside eukaryotic host cells. (A) Stationary-phase cultures were diluted 100-fold in BHI broth
and incubated at 37°C in aerobic and shaking conditions. Optical density values at 600 nm
(OD600) from each culture were measured every hour. (B) Intracellular multiplication in
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J774A.1 murine macrophages. Cells (2×105/well) were infected (45 min) with Lm, treated with
20 μg/ml gentamicin (75 min) and lysed at 2, 5, 7 and 20 h post-infection for quantification of
intracellular viable bacteria in BHI agar. S1 Table. Homology between the RmlACBD pro-
teins of Lm EGD-e and other strains and species. S2 Table. Primers.
(PDF)
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